In the Phase 3 EV-304 trial, statistically significant improvements in overall survival and pathological complete response were also observed, with over half of patients having no detectable disease ...

Closed, diagnosis-specific online communities provided psychologically safe space for young breast cancer survivors to ...

A retrospective study shows a synergistic interaction between Parkinson disease and stroke, leading to increased long-term mortality risk.

The REPLENISH trial finds secukinumab doubles the remission rate and significantly lowers steroid use in relapsing ...

The Binary Coin Days Destroyed (Binary CDD), which tracks whether long-term investors are moving dormant coins, currently ...

Enterprise AI adoption looks strong, but real ROI lags. Why coordination theater, shadow IT and stalled redesign are distorting compounding value.

We estimate that MRD represents a $20+ billion addressable market, growing at 30% annually, which we believe is less than 10% penetratedFORT MYERS, Fla.--(BUSINESS WIRE)--NeoGenomics, Inc. (NASDAQ: ...

Joining the call from Caris today are David Dean Halbert, our Founder, Chairman and CEO; David Spetzler, our President; Brian Brille, our Vice Chairman and EVP; Bobby Hill, our Chief Commercial ...

Explore the parallels and differences between AI architectures and the human brain's design and functionality in processing ...

A recent study published in the Journal of Internal Medicine found that people diagnosed with celiac disease undergo a increased long-term risk of developing acute pancreatitis for the first ...

Merck started 2026 on a high note. Read why MRK stock is still one of the best choices among Big Pharma players for long-term-oriented investors.

Consistent Revenue Growth: Immuron is no longer just a "concept" company. Global H1 FY26 sales grew to AUD$4.2 million, with the U.S. market showing strong momentum (+17% YoY). Cash (AUD $10.0 million ...